NASDAQ:HSDT Helius Medical Technologies (HSDT) Stock Price, News & Analysis $0.70 -0.08 (-10.22%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.65▼$0.7850-Day Range$0.70▼$1.4652-Week Range$0.65▼$13.43Volume139,427 shsAverage Volume88,733 shsMarket Capitalization$2.08 millionP/E RatioN/ADividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Helius Medical Technologies alerts: Email Address Helius Medical Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside3,313.9% Upside$24.00 Price TargetShort InterestHealthy1.49% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.29Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.63 out of 5 stars 3.5 Analyst's Opinion Consensus RatingHelius Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageHelius Medical Technologies has received no research coverage in the past 90 days.Read more about Helius Medical Technologies' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.49% of the outstanding shares of Helius Medical Technologies have been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently increased by 25.28%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HSDT. Previous Next 1.8 News and Social Media Coverage News SentimentHelius Medical Technologies has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for HSDT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.10% of the stock of Helius Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 18.63% of the stock of Helius Medical Technologies is held by institutions.Read more about Helius Medical Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Helius Medical Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Helius Medical Technologies Stock (NASDAQ:HSDT)Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Read More HSDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSDT Stock News HeadlinesJune 17, 2024 | globenewswire.comHelius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in StrokeMay 29, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance CarrierJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 24, 2024 | msn.comHelius Medical Technologies Showcases MS Therapy Progress at Annual MeetingMay 23, 2024 | finance.yahoo.comHelius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MSMay 23, 2024 | globenewswire.comHelius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MSMay 21, 2024 | msn.comHelius Medical's PoNS Device Gains Federal Supply Schedule ApprovalMay 20, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage ContractsJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 15, 2024 | msn.comHelius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke ProgramMay 14, 2024 | msn.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 Helius Medical Technologies Inc Earnings CallMay 14, 2024 | finance.yahoo.comHelius Medical Technologies Inc (HSDT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | globenewswire.comHelius Medical Technologies, Inc. Reports First Quarter 2024 Financial ResultsMay 10, 2024 | financialpost.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 10, 2024 | globenewswire.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 9, 2024 | msn.comHelius Medical Technologies Awaits CMS Decision on Medicare Reimbursement Rates for Innovative DeviceMay 7, 2024 | msn.comHelius Medical Technologies raises $6.4M via equity offeringSee More Headlines Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:HSDT CUSIPN/A CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees30Year Founded2014Price Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+3,313.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($13.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,850,000.00 Net Margins-1,328.14% Pretax Margin-1,328.14% Return on Equity-297.49% Return on Assets-107.36% Debt Debt-to-Equity RatioN/A Current Ratio3.51 Quick Ratio3.26 Sales & Book Value Annual Sales$640,000.00 Price / Sales3.25 Cash FlowN/A Price / Cash FlowN/A Book Value$3.32 per share Price / Book0.21Miscellaneous Outstanding Shares2,960,000Free Float2,812,000Market Cap$2.08 million OptionableNot Optionable Beta1.60 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 58)President, CEO & Director Comp: $469.17kDr. Antonella Favit-Van Pelt M.D. (Age 57)Ph.D., Chief Medical Officer Comp: $432.67kMr. Lawrence PiccianoSenior Vice President of Engineering, Quality & Regulatory AffairsKey CompetitorsGlucoTrackNASDAQ:GCTKSonendoNYSE:SONXIntelligent Bio SolutionsNASDAQ:INBSInnovative EyewearNASDAQ:LUCYSharps TechnologyNASDAQ:STSSView All CompetitorsInsidersDane AndreeffBought 5,000 shares on 12/14/2023Total: $40,500.00 ($8.10/share)Dane AndreeffBought 2,000 shares on 11/30/2023Total: $12,740.00 ($6.37/share)Dane AndreeffBought 5,000 shares on 8/30/2023Total: $38,200.00 ($7.64/share)Dane AndreeffBought 5,078 shares on 8/28/2023Total: $32,346.86 ($6.37/share)View All Insider Transactions HSDT Stock Analysis - Frequently Asked Questions How have HSDT shares performed this year? Helius Medical Technologies' stock was trading at $8.04 at the start of the year. Since then, HSDT stock has decreased by 91.3% and is now trading at $0.7030. View the best growth stocks for 2024 here. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies, Inc. (NASDAQ:HSDT) issued its earnings results on Monday, May, 13th. The company reported ($3.08) EPS for the quarter. The business earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative trailing twelve-month return on equity of 297.49%. When did Helius Medical Technologies' stock split? Shares of Helius Medical Technologies reverse split before market open on Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Helius Medical Technologies? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSDT) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
